fbpx
Donate Toggle Menu

Kidney cancer highlights from AUA 2023

Below are some of the research highlights from the 2023 American Urological Association Annual Meeting held on April 28 – May 1 in Chicago, Illinois.  Successful imaging of very small renal lesions New data from the phase…

AUA 2023 Highlight: Where does cytoreductive nephrectomy fit?

In a changing kidney cancer treatment landscape where immunotherapies and combination therapies have become more common as first-line treatments for patients, a number of presentations at the 2023 American Urological Association Annual Meeting held in…

You can’t be a bodybuilder with one kidney… can you?

This is a guest post by Annamarya Scaccia, a KCA Ambassador. Annamarya was diagnosed with kidney cancer in 2020. She is a certified fitness and nutrition coach who helps kidney cancer survivors optimize their performance…

Eating for Kidney Health: Q&A with Kate Zalewski, RDN, CSR, LDN

Kate Zalewski, RDN, CSR, LDN is an experienced renal dietitian who owns a virtual private practice primarily helping people with chronic kidney disease delay or avoid dialysis. KCA Ambassador Annamarya Scaccia spoke with her about…

Helping Dad Keep Up Quality Of Life Through Kidney Cancer

This is a guest post by Alexander Hutchison, PhD, who’s father-in-law was diagnosed with kidney cancer. Hutchison is a fitness expert and the senior editor of the scientific journal Advanced Biology & Aging Cell. In…

Making Healthier Choices After a Kidney Cancer Diagnosis

This is a guest post by Hector Perez, a KCA Ambassador. Hector was diagnosed with kidney cancer in 2006. After my kidney cancer diagnosis, I didn’t change any of my fitness or nutrition habits. I…

Who Benefits From Cytoreductive Nephrectomy? Q & A with Dr. Jose Karam 

A nephrectomy is surgery to remove all or part of a kidney, but when someone has surgery to remove a kidney tumor that has metastasized (spread) to other areas, the name for the procedure is called a cytoreductive nephrectomy. In years past, this procedure provided the best option to prolong survival for people with metastatic renal cell carcinoma (mRCC) because no effective pharmaceutical treatments existed for this patient group. 

2023 IKCS: Europe features three special lectures

The 2023 International Kidney Cancer Symposium: Europe, taking place in Edinburgh, Scotland on April 21-22, will feature three special lectures by prominent experts in kidney cancer. Register now.

Hector Perez’s kidney cancer journey

This is a guest post by Hector Perez, a KCA Ambassador. It’s been 12 years since I was diagnosed with renal cell carcinoma (RCC). There are still several nodules; however, they are under control and…

1 2 3 25